Rectal Cancer Presenting with Absceding Infection Due to Fusobacterium nucleatum
Abstract
:1. Introduction
2. Case Report
3. Discussion
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Weitz, J.; Koch, M.; Debus, J.; Höhler, T.; Galle, P.R.; Büchler, M.W. Colorectal Cancer. Lancet Lond. Engl. 2005, 365, 153–165. [Google Scholar] [CrossRef]
- Schmitt, M.; Greten, F.R. The Inflammatory Pathogenesis of Colorectal Cancer. Nat. Rev. Immunol. 2021, 21, 653–667. [Google Scholar] [CrossRef] [PubMed]
- Song, M.; Chan, A.T.; Sun, J. Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer. Gastroenterology 2020, 158, 322–340. [Google Scholar] [CrossRef] [PubMed]
- Yang, Y.; Weng, W.; Peng, J.; Hong, L.; Yang, L.; Toiyama, Y.; Gao, R.; Liu, M.; Yin, M.; Pan, C.; et al. Fusobacterium Nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-ΚB, and Up-Regulating Expression of MicroRNA-21. Gastroenterology 2017, 152, 851–866.e24. [Google Scholar] [CrossRef] [PubMed]
- Xu, C.; Fan, L.; Lin, Y.; Shen, W.; Qi, Y.; Zhang, Y.; Chen, Z.; Wang, L.; Long, Y.; Hou, T.; et al. Fusobacterium Nucleatum Promotes Colorectal Cancer Metastasis through MiR-1322/CCL20 Axis and M2 Polarization. Gut Microbes 2021, 13, 1980347. [Google Scholar] [CrossRef] [PubMed]
- Yu, T.; Guo, F.; Yu, Y.; Sun, T.; Ma, D.; Han, J.; Qian, Y.; Kryczek, I.; Sun, D.; Nagarsheth, N.; et al. Fusobacterium Nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell 2017, 170, 548–563.e16. [Google Scholar] [CrossRef] [PubMed]
- Schumacher, U.; Manncke, B.; Gerbracht, K.; Werner, H. In Vitro Activity of Meropenem Compared with Imipenem, Metronidazole, Ampicillin, and Ampicillin/Sulbactam against Anaerobes. Arzneimittel-Forschung 1994, 44, 859–862. [Google Scholar] [PubMed]
- Wang, S.; Liu, Y.; Li, J.; Zhao, L.; Yan, W.; Lin, B.; Guo, X.; Wei, Y. Fusobacterium Nucleatum Acts as a Pro-Carcinogenic Bacterium in Colorectal Cancer: From Association to Causality. Front. Cell Dev. Biol. 2021, 9, 710165. [Google Scholar] [CrossRef]
- Tilg, H.; Adolph, T.E.; Gerner, R.R.; Moschen, A.R. The Intestinal Microbiota in Colorectal Cancer. Cancer Cell 2018, 33, 954–964. [Google Scholar] [CrossRef] [PubMed]
- Bullman, S.; Pedamallu, C.S.; Sicinska, E.; Clancy, T.E.; Zhang, X.; Cai, D.; Neuberg, D.; Huang, K.; Guevara, F.; Nelson, T.; et al. Analysis of Fusobacterium Persistence and Antibiotic Response in Colorectal Cancer. Science 2017, 358, 1443–1448. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mesa, F.; Mesa-López, M.J.; Egea-Valenzuela, J.; Benavides-Reyes, C.; Nibali, L.; Ide, M.; Mainas, G.; Rizzo, M.; Magan-Fernandez, A. A New Comorbidity in Periodontitis: Fusobacterium Nucleatum and Colorectal Cancer. Medicina 2022, 58, 546. [Google Scholar] [CrossRef] [PubMed]
- Scheer, C.; Fuchs, C.; Gründling, M.; Vollmer, M.; Bast, J.; Bohnert, J.; Zimmermann, K.; Hahnenkamp, K.; Rehberg, S.; Kuhn, S.-O. Impact of Antibiotic Administration on Blood Culture Positivity at the Beginning of Sepsis: A Prospective Clinical Cohort Study. Clin. Microbiol. Infect. 2018, 25, 326–331. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Zundler, S.; Mardin, C.; Bertz, S.; Vitali, F.; Strauß, R.; Fürst, J.; Neurath, M.F.; Strobel, D. Rectal Cancer Presenting with Absceding Infection Due to Fusobacterium nucleatum. Pathogens 2022, 11, 1113. https://doi.org/10.3390/pathogens11101113
Zundler S, Mardin C, Bertz S, Vitali F, Strauß R, Fürst J, Neurath MF, Strobel D. Rectal Cancer Presenting with Absceding Infection Due to Fusobacterium nucleatum. Pathogens. 2022; 11(10):1113. https://doi.org/10.3390/pathogens11101113
Chicago/Turabian StyleZundler, Sebastian, Christian Mardin, Simone Bertz, Francesco Vitali, Richard Strauß, Julia Fürst, Markus F. Neurath, and Deike Strobel. 2022. "Rectal Cancer Presenting with Absceding Infection Due to Fusobacterium nucleatum" Pathogens 11, no. 10: 1113. https://doi.org/10.3390/pathogens11101113
APA StyleZundler, S., Mardin, C., Bertz, S., Vitali, F., Strauß, R., Fürst, J., Neurath, M. F., & Strobel, D. (2022). Rectal Cancer Presenting with Absceding Infection Due to Fusobacterium nucleatum. Pathogens, 11(10), 1113. https://doi.org/10.3390/pathogens11101113